02211.HK
Universal Health International Group Holding Limited
HKSE · Healthcare · Medical - Pharmaceuticals · CN
HKD 0.62
−5.34%Year over year
Reported trailing growth
- Revenue
- -42.8%
- EBITDA
- —
- EBIT
- —
- EPS
- —
- Free cash flow
- +37.3%
- Operating cash flow
- +37.4%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -17.6%
- EBITDA
- —
- EBIT
- —
- Net income
- —
- EPS
- —
- Free cash flow
- +41.1%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Dec 1, 2025